Peptron: Major Management Disclosure: IND Application (Phase 1 clinical trial application for PT403)
AI reading
★★★ Bullish · Material event
Application for Phase 1 clinical trial approval for obesity treatment PT403
Key figures: Number of clinical trial participants: 22
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
For information only. Not investment advice.